Correlation Between Avenue Therapeutics and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Avenue Therapeutics and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avenue Therapeutics and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avenue Therapeutics and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Avenue Therapeutics and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avenue Therapeutics with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avenue Therapeutics and Quoin Pharmaceuticals.
Diversification Opportunities for Avenue Therapeutics and Quoin Pharmaceuticals
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Avenue and Quoin is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Avenue Therapeutics and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Avenue Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avenue Therapeutics are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Avenue Therapeutics i.e., Avenue Therapeutics and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Avenue Therapeutics and Quoin Pharmaceuticals
Given the investment horizon of 90 days Avenue Therapeutics is expected to under-perform the Quoin Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Avenue Therapeutics is 2.13 times less risky than Quoin Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Quoin Pharmaceuticals Ltd is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 62.00 in Quoin Pharmaceuticals Ltd on September 13, 2024 and sell it today you would earn a total of 15.00 from holding Quoin Pharmaceuticals Ltd or generate 24.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Avenue Therapeutics vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Avenue Therapeutics |
| Quoin Pharmaceuticals |
Avenue Therapeutics and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avenue Therapeutics and Quoin Pharmaceuticals
The main advantage of trading using opposite Avenue Therapeutics and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avenue Therapeutics position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Neurobo Pharmaceuticals | Avenue Therapeutics vs. Virax Biolabs Group |
| Quoin Pharmaceuticals vs. Puma Biotechnology | Quoin Pharmaceuticals vs. Iovance Biotherapeutics | Quoin Pharmaceuticals vs. Sarepta Therapeutics | Quoin Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |